T he prevalence of diabetes mellitus (DM) is increasing rapidly due to a growing obesity epidemic and an aging Western population (1) . Incremental cardiovascular risk associated with DM over the short term has been documented in both single-center studies and through the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry (2) . In addition, it has been shown that coronary stenosis confers additive risk prediction beyond both calcium scoring and nonobstructive disease on coronary computed tomography angiography (CTA) over shortto intermediate-term follow-up (3) .
To date, the prognostic value of CTA in patients with DM over the long term has not been well elucidated, with current knowledge limited to small single-center studies (4, 5) . In addition, the relative risk of patients with DM with both nonobstructive and obstructive disease on coronary CTA compared with nondiabetic subjects over the long term is unknown. We accordingly performed an analysis to determine the long-term prognostic value of coronary CTA among patients with DM compared with nondiabetic subjects in a large, prospective, multicenter international coronary CTA registry (CONFIRM).
MATERIALS AND METHODS
The CONFIRM registry is a prospective, international, multicenter registry designed to evaluate the relationship of coronary atherosclerosis and clinical risk factors to adverse outcomes among patients who have undergone at least 64-slice clinically indicated coronary CTA. The rationale and design of CONFIRM have been reported previously (6) . For the present analysis, the primary study cohort comprised patients included in the CONFIRM registry with 5-year follow-up (allcause mortality) and DM but no history of known coronary artery disease (CAD) (myocardial infarction or revascularization before the scan date). A subgroup analysis was also performed among patients with 5- year major adverse cardiovascular event (MACE) follow-up. For comparison, a propensity-matched cohort of patients without DM or a history of known CAD who also had 5-year follow-up were identified. Table 2 . Table 2) . Importantly, risk-adjusted mortality was increased among patients with nonobstructive CAD compared with patients without evidence of CAD (p ¼ 0.001). Figures 4A and 4B , respectively. In a riskadjusted hazard analysis based on the extent of CAD, a dose-response relationship between the number of coronary vessels exhibiting obstructive CAD and MACE occurrence was noted ( Table 4 ). In addition, the worsened prognosis associated with extent of CAD held true across symptom status and type ( Table 5 ).
CLINICAL EVALUATION AND CARDIAC RISK FACTOR

DISCUSSION
To the best of our knowledge, our analysis represents the largest evaluation of the long-term prognostic value of coronary CTA-identified CAD in patients with DM. The main findings of our analysis are that when propensity-matched to nondiabetic subjects, those with DM without atherosclerosis have a similar Obs ¼ obstructive; other abbreviations as in Figure 1 . Blanke et al. 
